Literature DB >> 14715140

Cell-specific alternative splicing increases calcium channel current density in the pain pathway.

Thomas J Bell1, Christopher Thaler, Andrew J Castiglioni, Thomas D Helton, Diane Lipscombe.   

Abstract

N-type calcium channels are critical for pain transduction. Inhibitors of these channels are powerful analgesics, but clinical use of current N-type blockers remains limited by undesirable actions in other regions of the nervous system. We now demonstrate that a unique splice isoform of the N-type channel is restricted exclusively to dorsal root ganglia. By a combination of functional and molecular analyses at the single-cell level, we show that the DRG-specific exon, e37a, is preferentially present in Ca(V)2.2 mRNAs expressed in neurons that contain nociceptive markers, VR1 and Na(V)1.8. Cell-specific inclusion of exon 37a correlates closely with significantly larger N-type currents in nociceptive neurons. This unique splice isoform of the N-type channel could represent a novel target for pain management.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715140     DOI: 10.1016/s0896-6273(03)00801-8

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  93 in total

1.  A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY.

Authors:  Matthew S Ripsch; Carrie J Ballard; May Khanna; Joyce H Hurley; Fletcher A White; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2012-03       Impact factor: 1.757

2.  Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury.

Authors:  J B McCallum; H-E Wu; Q Tang; W-M Kwok; Q H Hogan
Journal:  Neuroscience       Date:  2011-01-28       Impact factor: 3.590

3.  Alternative splicing as a molecular switch for Ca2+/calmodulin-dependent facilitation of P/Q-type Ca2+ channels.

Authors:  Dipayan Chaudhuri; Siao-Yun Chang; Carla D DeMaria; Rebecca S Alvania; Tuck Wah Soong; David T Yue
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

Review 4.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 5.  Calcium channel functions in pain processing.

Authors:  John Park; Z David Luo
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

6.  Src family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.

Authors:  Guohua Zhang; Wenling Chen; Juan Carlos G Marvizón
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

7.  Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein Motifs.

Authors:  Natsuko Macabuag; Annette C Dolphin
Journal:  J Neurosci       Date:  2015-10-28       Impact factor: 6.167

8.  Importance of voltage-dependent inactivation in N-type calcium channel regulation by G-proteins.

Authors:  Norbert Weiss; Abir Tadmouri; Mohamad Mikati; Michel Ronjat; Michel De Waard
Journal:  Pflugers Arch       Date:  2006-12-14       Impact factor: 3.657

9.  Molecular basis of Ca(v)2.3 calcium channels in rat nociceptive neurons.

Authors:  Zhi Fang; Chul-Kyu Park; Hai Ying Li; Hyun Yeong Kim; Seong-Hae Park; Sung Jun Jung; Joong Soo Kim; Arnaud Monteil; Seog Bae Oh; Richard J Miller
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

10.  Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.

Authors:  Xian Xuan Chi; Brian S Schmutzler; Joel M Brittain; Yuying Wang; Cynthia M Hingtgen; Grant D Nicol; Rajesh Khanna
Journal:  J Cell Sci       Date:  2009-11-10       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.